PharmTech News

Dec 18, 2017
By Pharmaceutical Technology Editors
Cycle and Aprecia will use Aprecia's 3DP Technology to improve rare disease drug formulations.
Dec 18, 2017
By Pharmaceutical Technology Editors
The US Court of Appeals for the Federal Circuit has decided in favor of Novartis’ Sandoz in rendering the opinion that Amgen cannot use state laws to prohibit or delay the marketing of biosimilars.
Dec 15, 2017
By Pharmaceutical Technology Editors
Research into an old antibiotic might open the door for new drugs to treat tuberculosis and other related microbial diseases.
Dec 14, 2017
By Pharmaceutical Technology Editors
Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate (ADC) to clinical trials.
Dec 14, 2017
By Pharmaceutical Technology Editors
Children with a rare brainstem-based cancer might be helped by a new immunotherapy that targets a mutated protein found exclusively in cancer cells.
Dec 14, 2017
By Pharmaceutical Technology Editors
The draft guidance gives recommendations on how certain oral drug products should be labeled regarding gluten.
Dec 14, 2017
By Pharmaceutical Technology Editors
The Quattroflow QF10k size pump from PSG, a Dover company, has been added to its line of quaternary, four-piston diaphragm pumps.
Dec 14, 2017
By Pharmaceutical Technology Editors
FDA has approved a Pfizer biosimilar to J&J’s top-selling anti-inflammatory biologic, Remicade.
Dec 14, 2017
By Pharmaceutical Technology Editors
The company is seeking approval from FDA for use of the drug, migalastat, to treat Fabry disease in patients who have amenable mutations.
Dec 13, 2017
By Pharmaceutical Technology Editors
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
native1_300x100
lorem ipsum